<p>(A) Schematic representation of the experiment procedures. Primary MDDCs and autologous resting CD4<sup>+</sup> T cells were used. (B) DCs infected with replication-competent WT or Nef-mutated HIV-1 were co-cultured with uninfected resting CD4<sup>+</sup> T cells and HIV-1 p24 production in the supernatants was measured at the indicated times of co-cultures. Immature DCs were generated from purified monocytes by treatment with GM-CSF and IL-4 for 5 days. Resting CD4<sup>+</sup> T cells were isolated from PBMCs using immunomagnetic particles and were cultured in the presence of IL-2 for 8 days. (C) Co-culture with HIV-1-infected DCs increases the surface expression of the transient T-cell activation marker CD69 on resting CD4<sup>+</sup> ...
<p>(A) Autologous naïve bulk (CD4<sup>+</sup> and CD8<sup>+</sup>) T cells were negatively isolated ...
<p>(A) Diagram of the HIV Duo-Fluo I virus, in which eGFP has replaced the <i>nef</i> gene, and a wh...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
<p>Resting CD4<sup>+</sup> T cells were isolated from PBMCs using immunomagnetic particles and were ...
<p>(A) HIV-1 Nef increases the expression of the transient T-cell activation marker CD69 in resting ...
<p>T cell proliferation in response to autologous MDDC infected with MVA-B at 1 PFU/MDDC in a 6-day ...
<p>MDDCs exposed to HIV-1<sub>BaL</sub>(pellet) or HIV-1<sub>BaL</sub>(CD45<sup>−</sup>) for 48 hour...
<p>IFNγ induction in both CD4<sup>+</sup><i>(A)</i> and CD8<sup>+</sup><i>(B)</i> T cell clones by C...
<p>(<b>A</b>) Resting CD4<sup>+</sup> T cells were isolated from the blood of healthy donors and lab...
<p>MDDCs were either untreated or exposed to HIV-1<sub>BaL</sub>(pellet), HIV-1<sub>BaL</sub>(CD45<s...
<p>MoDC were infected with HIV<sub>BAL</sub> and cultured with CFDA-SE labeled Vγ9Vδ2 T cells. After...
HIV preferentially establishes productive infection in activated CD4+ T cells. Since proportions of ...
<p>(A) moDCs differentiated from purified CD14<sup>+</sup> monocytes were stimulated with or without...
DCs act as sentinel cells against incoming pathogens and represent the most potent antigen presentin...
<p>(A) Resting or pre-activated (CD3/CD28 beads, two beads per cell) CD4 T cells (1×10<sup>6</sup>) ...
<p>(A) Autologous naïve bulk (CD4<sup>+</sup> and CD8<sup>+</sup>) T cells were negatively isolated ...
<p>(A) Diagram of the HIV Duo-Fluo I virus, in which eGFP has replaced the <i>nef</i> gene, and a wh...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...
<p>Resting CD4<sup>+</sup> T cells were isolated from PBMCs using immunomagnetic particles and were ...
<p>(A) HIV-1 Nef increases the expression of the transient T-cell activation marker CD69 in resting ...
<p>T cell proliferation in response to autologous MDDC infected with MVA-B at 1 PFU/MDDC in a 6-day ...
<p>MDDCs exposed to HIV-1<sub>BaL</sub>(pellet) or HIV-1<sub>BaL</sub>(CD45<sup>−</sup>) for 48 hour...
<p>IFNγ induction in both CD4<sup>+</sup><i>(A)</i> and CD8<sup>+</sup><i>(B)</i> T cell clones by C...
<p>(<b>A</b>) Resting CD4<sup>+</sup> T cells were isolated from the blood of healthy donors and lab...
<p>MDDCs were either untreated or exposed to HIV-1<sub>BaL</sub>(pellet), HIV-1<sub>BaL</sub>(CD45<s...
<p>MoDC were infected with HIV<sub>BAL</sub> and cultured with CFDA-SE labeled Vγ9Vδ2 T cells. After...
HIV preferentially establishes productive infection in activated CD4+ T cells. Since proportions of ...
<p>(A) moDCs differentiated from purified CD14<sup>+</sup> monocytes were stimulated with or without...
DCs act as sentinel cells against incoming pathogens and represent the most potent antigen presentin...
<p>(A) Resting or pre-activated (CD3/CD28 beads, two beads per cell) CD4 T cells (1×10<sup>6</sup>) ...
<p>(A) Autologous naïve bulk (CD4<sup>+</sup> and CD8<sup>+</sup>) T cells were negatively isolated ...
<p>(A) Diagram of the HIV Duo-Fluo I virus, in which eGFP has replaced the <i>nef</i> gene, and a wh...
Background: Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, ho...